Role of Fas (CD95) in tubulointerstitial disease induced by unilateral ureteric obstruction

被引:31
作者
Hughes, J [1 ]
Johnson, RJ [1 ]
机构
[1] Univ Washington, Dept Med, Div Nephrol, Seattle, WA 98195 USA
关键词
Fas ligand; apoptosis; tubular epithelial cell; kidney; myofibroblast;
D O I
10.1152/ajprenal.1999.277.1.F26
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Murine renal tubular epithelial cells and interstitial fibroblasts may express both Fas (CD95) death receptor and Fas ligand and are vulnerable to Fas-mediated death in vitro. We therefore hypothesized that an absence of renal Fas may protect resident cells from undergoing apoptosis. We performed unilateral ureteric ligation [producing unilateral ureteral obstruction (UUO)] in 6-wk-old normal central mice and C57B16/lpr mice, which express a nonfunctional Fas receptor. Obstructed kidneys were removed at days 3, 7, and 14 (n = 6 per group). Tubular cell apoptosis at day 7 was significantly reduced in lpr mice [21.8 +/- 5.8 vs. 45.7 +/- 7.6 cells/10 high-power fields (hpf), P < 0.02]. Importantly, there was no difference in tubular cell proliferation between normal and lpr mice at any time point studied. Interestingly, double labeling with terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) and the proximal tubule-specific antibody Fx1A indicated that the absence of Fas reduced distal but; not proximal tubular death at clay 7. In addition, there was no difference in interstitial cell. apoptosis or proliferation, suggesting that Fas does ndt play a significant role in interstitial cell death. Importantly, inflammatory macrophage in filtration and ultimate collagen I deposition was unchanged in lpr mice. In conclusion, the absence of functional cell surface Fas in UUO provides distal tubular cells with partial protection from apoptosis but; does not affect interstitial cell fate in this model of tubulointerstitial injury.
引用
收藏
页码:F26 / F32
页数:7
相关论文
共 31 条
[1]   MESANGIAL CELL APOPTOSIS - THE MAJOR MECHANISM FOR RESOLUTION OF GLOMERULAR HYPERCELLULARITY IN EXPERIMENTAL MESANGIAL PROLIFERATIVE NEPHRITIS [J].
BAKER, AJ ;
MOONEY, A ;
HUGHES, J ;
LOMBARDI, D ;
JOHNSON, RJ ;
SAVILL, J .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (05) :2105-2116
[2]  
Bohle A, 1996, KIDNEY INT, V49, pS2
[3]  
BOONSTRA JG, 1997, J AM SOC NEPHROL, V8, P1717
[4]   The role of Fas in autoimmune diabetes [J].
Chervonsky, AV ;
Wang, Y ;
Wong, FS ;
Visintin, I ;
Flavell, RA ;
Janeway, CA ;
Matis, LA .
CELL, 1997, 89 (01) :17-24
[5]   FADD, A NOVEL DEATH DOMAIN-CONTAINING PROTEIN, INTERACTS WITH THE DEATH DOMAIN OF FAS AND INITIATES APOPTOSIS [J].
CHINNAIYAN, AM ;
OROURKE, K ;
TEWARI, M ;
DIXIT, VM .
CELL, 1995, 81 (04) :505-512
[6]  
COLES HSR, 1993, DEVELOPMENT, V118, P777
[7]  
DESMOULIERE A, 1995, EXP NEPHROL, V3, P134
[8]   MACROPHAGES AND PROGRESSIVE RENAL-DISEASE IN EXPERIMENTAL HYDRONEPHROSIS [J].
DIAMOND, JR .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 26 (01) :133-140
[9]  
DIAMOND JR, 1995, AM J PATHOL, V146, P121
[10]   Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain [J].
Dowling, P ;
Shang, GF ;
Raval, S ;
Menonna, J ;
Cook, S ;
Husar, W .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (04) :1513-1518